{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:54:44Z","timestamp":1787928884336,"version":"build-2784847793"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU-12010\/4"],"award-info":[{"award-number":["MC_UU-12010\/4"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","award":["RP150066"],"award-info":[{"award-number":["RP150066"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["207547\/Z\/17\/Z"],"award-info":[{"award-number":["207547\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.immuni.2024.01.007","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T10:31:51Z","timestamp":1707820311000},"page":"256-270.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases"],"prefix":"10.1016","volume":"57","author":[{"given":"Anna H.","family":"Lippert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Paluch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Gaglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai T.","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"McColl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fellermeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumana","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Moreira da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billur","family":"Akkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Anzilotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara H.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire F.","family":"Jessup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"K\u00f6rbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzi","family":"Gileadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Leitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Knox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Chirifu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Ashman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrine E.","family":"Attfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Fugger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan J.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Steinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mafalda","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven F.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Cornall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Klenerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2280-1170","authenticated-orcid":false,"given":"Simon J.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2024.01.007_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-065X.2009.00770.x","article-title":"CD28 and CTLA-4 coreceptor expression and signal transduction","volume":"229","author":"Rudd","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2024.01.007_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T\u00a0cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib3","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/imr.12008","article-title":"Non-catalytic tyrosine-phosphorylated receptors","volume":"250","author":"Dushek","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2024.01.007_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12929-017-0329-9","article-title":"Cancer immunotherapies targeting the PD-1 signaling pathway","volume":"24","author":"Iwai","year":"2017","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.immuni.2024.01.007_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.immuni.2024.01.007_bib6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1146\/annurev-immunol-032414-112049","article-title":"Coinhibitory Pathways in Immunotherapy for Cancer","volume":"34","author":"Baumeister","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.cell.2015.07.045","article-title":"PD-1 Blockers","volume":"162","author":"Wolchok","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.01.007_bib8","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.4049\/jimmunol.124.6.2708","article-title":"OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties","volume":"124","author":"Van Wauwe","year":"1980","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/eji.1830270136","article-title":"CD28-mediated induction of proliferation in resting T\u00a0cells in\u00a0vitro and in\u00a0vivo without engagement of the T\u00a0cell receptor: evidence for functionally distinct forms of CD28","volume":"27","author":"Tacke","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib10","first-page":"740","article-title":"Storm forecasting: additional lessons from the CD28 superagonist TGN1412 trial","volume":"12","author":"Horvath","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239595","article-title":"ICOS agonism by JTX-2011 (vopratelimab) requires initial T\u00a0cell priming and Fc cross-linking for optimal T\u00a0cell activation and anti-tumor immunity in preclinical models","volume":"15","author":"Hanson","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.immuni.2024.01.007_bib12","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.3389\/fimmu.2018.02306","article-title":"Immune Checkpoints as Therapeutic Targets in Autoimmunity","volume":"9","author":"Paluch","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib13","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1056\/NEJMoa2209856","article-title":"A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis","volume":"388","author":"Tuttle","year":"2023","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2024.01.007_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrd.2018.75","article-title":"The promise and challenges of immune agonist antibody development in cancer","volume":"17","author":"Mayes","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.immuni.2024.01.007_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrd.2017.227","article-title":"Next generation antibody drugs: pursuit of the 'high-hanging fruit'","volume":"17","author":"Carter","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.immuni.2024.01.007_bib16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.seminoncol.2017.06.007","article-title":"Nivolumab and pembrolizumab: Monoclonal antibodies against programmed cell death-1 (PD-1) that are interchangeable","volume":"44","author":"Prasad","year":"2017","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.immuni.2024.01.007_bib17","first-page":"75","article-title":"Role of PD-1 in Immunity and Diseases","volume":"410","author":"Chamoto","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ccell.2015.08.004","article-title":"Fc\u03b3Rs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1\/PD-L1 Axis","volume":"28","author":"Dahan","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2024.01.007_bib19","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00262-018-2160-x","article-title":"The binding of an anti-PD-1 antibody to Fc\u03b3RIota has a profound impact on its biological functions","volume":"67","author":"Zhang","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.immuni.2024.01.007_bib20","doi-asserted-by":"crossref","first-page":"eadd4947","DOI":"10.1126\/sciimmunol.add4947","article-title":"Anti-PD-1 antibodies recognizing the membrane-proximal region are PD-1 agonists that can down-regulate inflammatory diseases","volume":"8","author":"Suzuki","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/ni1369","article-title":"The kinetic-segregation model: TCR triggering and beyond","volume":"7","author":"Davis","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/ni1170","article-title":"Crystal structure of a soluble CD28-Fab complex","volume":"6","author":"Evans","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/intimm\/dxg063","article-title":"Mitogenic signals through CD28 activate the protein kinase Ctheta-NF-kappaB pathway in primary peripheral T\u00a0cells","volume":"15","author":"Dennehy","year":"2003","journal-title":"Int. Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib24","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.4049\/jimmunol.178.3.1363","article-title":"Mitogenic CD28 signals require the exchange factor Vav1 to enhance TCR signaling at the SLP-76-Vav-Itk signalosome","volume":"178","author":"Dennehy","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib25","doi-asserted-by":"crossref","first-page":"15419","DOI":"10.1074\/jbc.M709000200","article-title":"Inhibition of ZAP-70 kinase activity via an analog-sensitive allele blocks T\u00a0cell receptor and CD28 superagonist signaling","volume":"283","author":"Levin","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.immuni.2024.01.007_bib26","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1084\/jem.20021024","article-title":"Topological requirements and signaling properties of T\u00a0cell-activating, anti-CD28 antibody superagonists","volume":"197","author":"L\u00fchder","year":"2003","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2024.01.007_bib27","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.4049\/jimmunol.175.3.1575","article-title":"A Theoretical Framework for Quantitative Analysis of the Molecular Basis of Costimulation","volume":"175","author":"Jansson","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib28","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ni.3392","article-title":"Initiation of T\u00a0cell signaling by CD45 segregation at 'close contacts'","volume":"17","author":"Chang","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0960-9822(00)00362-6","article-title":"Exclusion of CD45 from the T-cell receptor signaling area in antigen-stimulated T lymphocytes","volume":"10","author":"Leupin","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.immuni.2024.01.007_bib30","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.4049\/jimmunol.161.7.3249","article-title":"CD148: a receptor-type protein tyrosine phosphatase involved in the regulation of human T\u00a0cell activation","volume":"161","author":"Tangye","year":"1998","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib31","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024250118","article-title":"Trapping or slowing the diffusion of T\u00a0cell receptors at close contacts\u00a0initiates T\u00a0cell signaling","volume":"118","author":"Chen","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2024.01.007_bib32","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1158\/2326-6066.CIR-14-0040","article-title":"In\u00a0vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in\u00a0vivo toxicology in non-human primates","volume":"2","author":"Wang","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.immuni.2024.01.007_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jim.2010.09.020","article-title":"T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T\u00a0cells","volume":"362","author":"Leitner","year":"2010","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.immuni.2024.01.007_bib34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/74704","article-title":"Inhibitory Fc receptors modulate in\u00a0vivo cytotoxicity against tumor targets","volume":"6","author":"Clynes","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2024.01.007_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T\u00a0cell activation","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib36","doi-asserted-by":"crossref","first-page":"13866","DOI":"10.1073\/pnas.231486598","article-title":"PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine","volume":"98","author":"Okazaki","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2024.01.007_bib37","doi-asserted-by":"crossref","first-page":"e201905085","DOI":"10.1083\/jcb.201905085","article-title":"PD-1 and BTLA regulate T\u00a0cell signaling differentially and only partially through SHP1 and SHP2","volume":"219","author":"Xu","year":"2020","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.immuni.2024.01.007_bib38","doi-asserted-by":"crossref","first-page":"14369","DOI":"10.1038\/ncomms14369","article-title":"An unexpected N-terminal loop in PD-1 dominates binding by nivolumab","volume":"8","author":"Tan","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2024.01.007_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/cr.2016.77","article-title":"Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab","volume":"27","author":"Na","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.immuni.2024.01.007_bib40","series-title":"Modulation of the PD-1 Pathway by Inhibitory Antibody Superagonists","author":"Akkaya","year":"2012"},{"key":"10.1016\/j.immuni.2024.01.007_bib41","doi-asserted-by":"crossref","DOI":"10.3791\/53319-v","article-title":"The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL\/6 Mice","author":"Klarquist","year":"2015","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.immuni.2024.01.007_bib42","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4049\/jimmunol.1502241","article-title":"Loss of Immune Tolerance Is Controlled by ICOS in Sle1 Mice","volume":"197","author":"Mittereder","year":"2016","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cell.2018.05.059","article-title":"Size-Dependent Segregation Controls Macrophage Phagocytosis of Antibody-Opsonized Targets","volume":"174","author":"Bakalar","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.01.007_bib44","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1126\/science.1118948","article-title":"Divergent immunoglobulin g subclass activity through selective Fc receptor binding","volume":"310","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.immuni.2024.01.007_bib45","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1016\/j.bpj.2011.05.013","article-title":"Mechanisms for Size-Dependent Protein Segregation at Immune Synapses Assessed with Molecular Rulers","volume":"100","author":"Alakoskela","year":"2011","journal-title":"Biophys. J."},{"key":"10.1016\/j.immuni.2024.01.007_bib46","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nphys3678","article-title":"Size-dependent protein segregation at membrane interfaces","volume":"12","author":"Schmid","year":"2016","journal-title":"Nat. Phys."},{"key":"10.1016\/j.immuni.2024.01.007_bib47","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.bpj.2020.01.019","article-title":"The Costs of Close Contacts: Visualizing the Energy Landscape of Cell Contacts at the Nanoscale","volume":"118","author":"Kulenkampff","year":"2020","journal-title":"Biophys. J."},{"key":"10.1016\/j.immuni.2024.01.007_bib48","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/s41467-023-36855-9","article-title":"Antigen discrimination by T\u00a0cells relies on size-constrained microvillar contact","volume":"14","author":"Jenkins","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2024.01.007_bib49","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.yexcr.2008.10.008","article-title":"Interaction of antibodies with ErbB receptor extracellular regions","volume":"315","author":"Schmitz","year":"2009","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.immuni.2024.01.007_bib50","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.it.2018.05.005","article-title":"\u03b1\u03b2 T Cell Receptor Mechanosensing Forces out Serial Engagement","volume":"39","author":"Feng","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib51","doi-asserted-by":"crossref","first-page":"1147467","DOI":"10.3389\/fimmu.2023.1147467","article-title":"Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectives","volume":"14","author":"Dadas","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1365-3083.1999.00580.x","article-title":"Why so many coinhibitory receptors?","volume":"50","author":"Sinclair","year":"1999","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib53","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fimmu.2019.00292","article-title":"Fc\u03b3R-Binding Is an Important Functional Attribute for Immune Checkpoint Antibodies in Cancer Immunotherapy","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib54","doi-asserted-by":"crossref","first-page":"e003735","DOI":"10.1136\/jitc-2021-003735","article-title":"Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environments","volume":"10","author":"Moreno-Vicente","year":"2022","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.immuni.2024.01.007_bib55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrd3365","article-title":"Advances in the assessment and control of the effector functions of therapeutic antibodies","volume":"10","author":"Jiang","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.immuni.2024.01.007_bib56","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2024.01.007_bib57","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1182\/blood-2014-08-593061","article-title":"Upregulation of Fc\u03b3RIIb on monocytes is necessary to promote the superagonist activity of TGN1412","volume":"125","author":"Hussain","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2024.01.007_bib58","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1200\/JCO.21.01926","article-title":"Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study","volume":"40","author":"Shen","year":"2022","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.immuni.2024.01.007_bib59","doi-asserted-by":"crossref","first-page":"eaal3604","DOI":"10.1126\/scitranslmed.aal3604","article-title":"In\u00a0vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy","volume":"9","author":"Arlauckas","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2024.01.007_bib60","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1038\/s41467-020-18828-4","article-title":"Structural characterization of the ICOS\/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies","volume":"11","author":"Rujas","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2024.01.007_bib61","doi-asserted-by":"crossref","first-page":"eaat0756","DOI":"10.1126\/scisignal.aat0756","article-title":"CD45 exclusion\u2013 and cross-linking\u2013based receptor signaling together broaden Fc\u03b5RI reactivity","volume":"11","author":"Felce","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.immuni.2024.01.007_bib62","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41586-020-2851-2","article-title":"Immune receptor inhibition through enforced phosphatase recruitment","volume":"586","author":"Fernandes","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.01.007_bib63","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0092-8674(85)80103-3","article-title":"The T\u00a0cell receptor: the alpha and beta chains define idiotype, and antigen and MHC specificity","volume":"42","author":"Yag\u00fce","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.01.007_bib64","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1084\/jem.186.9.1441","article-title":"Selection of Antigen-specific T Cells by a Single IEk Peptide Combination","volume":"186","author":"Liu","year":"1997","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2024.01.007_bib65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00005-020-00579-1","article-title":"BW5147 and Derivatives for the Study of T Cells and their Antigen Receptors","volume":"68","author":"White","year":"2020","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.immuni.2024.01.007_bib66","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4049\/jimmunol.133.1.123","article-title":"The role of T3 surface molecules in the activation of human T\u00a0cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level","volume":"133","author":"Weiss","year":"1984","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib67","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1440-1711.1998.00709.x","article-title":"Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements","volume":"76","author":"Barnden","year":"1998","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.immuni.2024.01.007_bib68","doi-asserted-by":"crossref","first-page":"eabg1703","DOI":"10.1126\/sciimmunol.abg1703","article-title":"HLA-E-restricted, Gag-specific CD8+ T\u00a0cells can suppress HIV-1 infection, offering vaccine opportunities","volume":"6","author":"Yang","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2024.01.007_bib69","doi-asserted-by":"crossref","first-page":"11771","DOI":"10.1074\/jbc.M112.448126","article-title":"Structure and interactions of the human programmed cell death 1 receptor","volume":"288","author":"Cheng","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.immuni.2024.01.007_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsb.2016.01.016","article-title":"Easy mammalian expression and crystallography of maltose-binding protein-fused human proteins","volume":"194","author":"Bokhove","year":"2016","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.immuni.2024.01.007_bib71","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.str.2007.01.011","article-title":"Glycoprotein structural genomics: solving the glycosylation problem","volume":"15","author":"Chang","year":"2007","journal-title":"Structure"},{"key":"10.1016\/j.immuni.2024.01.007_bib72","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.immuni.2024.01.007_bib73","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of Macromolecular Structures by the Maximum-Likelihood Method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2024.01.007_bib74","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2024.01.007_bib75","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/nprot.2008.91","article-title":"Automated macromolecular model building for X-ray crystallography using ARP\/wARP version 7","volume":"3","author":"Langer","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.immuni.2024.01.007_bib76","doi-asserted-by":"crossref","first-page":"16487","DOI":"10.1038\/srep16487","article-title":"CalQuo: automated, simultaneous single-cell and population-level quantification of global intracellular Ca2+ responses","volume":"5","author":"Fritzsche","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.immuni.2024.01.007_bib77","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.14440\/jbm.2014.36","article-title":"Advanced methods of microscope control using \u03bcManager software","volume":"1","author":"Edelstein","year":"2014","journal-title":"J.\u00a0Biol. Methods"},{"key":"10.1016\/j.immuni.2024.01.007_bib78","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","article-title":"Array programming with NumPy","volume":"585","author":"Harris","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.01.007_bib79","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.7717\/peerj.453","article-title":"scikit-image: image processing in Python","volume":"2","author":"van der Walt","year":"2014","journal-title":"PeerJ"},{"key":"10.1016\/j.immuni.2024.01.007_bib80","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41592-019-0364-4","article-title":"Super-resolution fight club: assessment of 2D and 3D single-molecule localization microscopy software","volume":"16","author":"Sage","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.immuni.2024.01.007_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064287","article-title":"A quantitative comparison of single-dye tracking analysis tools using Monte Carlo simulations","volume":"8","author":"Weimann","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.immuni.2024.01.007_bib82","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nmeth.2367","article-title":"Extracting intracellular diffusive states and transition rates from single-molecule tracking data","volume":"10","author":"Persson","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.immuni.2024.01.007_bib83","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.4049\/jimmunol.1302750","article-title":"STAT3, STAT4, NFATc1, and CTCF regulate PD-1 through multiple novel regulatory regions in murine T\u00a0cells","volume":"192","author":"Austin","year":"2014","journal-title":"J.\u00a0Immunol."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761324000335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761324000335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T15:40:55Z","timestamp":1721058055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761324000335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1074761324000335"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2024.01.007","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2024.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}